Lilly K Latest - Search News

News

Eli Lilly Vows to Make Weight-Loss Pill in U.S.

Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

KFF Health News · 1d

Amid Tariff Threats, Lilly Vows To Make New Weight Loss Pill In US

Meanwhile, Stat reports that in Ireland — a global pharmaceutical hub — potential U.S. tariffs are raising concerns. Also in the news: Novo Nordisk, PBM legislation in statehouses, same-day prescription deliveries,

Fox News · 4d

First GLP-1 pill for weight loss, diabetes shows success in late-phase trial

Injectables for type 2 diabetes and weight loss could soon be a thing of the past. Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small ...

Medscape22h

Dramatic Uptake of Tirzepatide Seen for T2D and Weight Loss

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

The Motley Fool2d

Is Eli Lilly Stock a Buy Right Now?

Eli Lilly stock has been a big-time winner over the last couple of years, but looming tariffs are worrying some investors. The pharmaceutical sector could be the next industry to face sweeping ...

New York Post4d

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

USA Today5d

Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.

The Motley Fool2d

Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock

Drugmaker Eli Lilly (LLY 14.56%) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results